XTANDI 40 MG CAP MOLE CT ENVOL BL AL PLAS PVC/PCTFE TRANS X 120
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1771700060021 -
GGREM
540315030002702 -
Código de barras
7899337000707
O que a fonte publica
- Detentor do registro
- ASTELLAS FARMA BRASIL IMPORTAÇÃO E DISTRIBUIÇÃO DE MEDICAMENTOS LTDA.
- Princípios ativos
- ENZALUTAMIDA
- Embalagem
- 40 MG CAP MOLE CT ENVOL BL AL PLAS PVC/PCTFE TRANS X 120
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L2B2 - HORMÔNIOS ANTIANDROGÊNICOS CITOSTÁTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "XTANDI 40 MG CAP MOLE CT ENVOL BL AL PLAS PVC/PCTFE TRANS X 120",
"holder": "ASTELLAS FARMA BRASIL IMPORTAÇÃO E DISTRIBUIÇÃO DE MEDICAMENTOS LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7899337000707"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "540315030002702",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "07.768.134/0001-04",
"priceRegime": "Regulado",
"productName": "XTANDI",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "40 MG CAP MOLE CT ENVOL BL AL PLAS PVC/PCTFE TRANS X 120",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "12514.57",
"icms-12": "14221.11",
"icms-17": "15077.79",
"icms-18": "15261.67",
"icms-19": "15450.09",
"icms-20": "15643.21",
"icms-21": "15841.23",
"icms-22": "16044.32",
"icms-23": "16252.68",
"icms-17.5": "15169.17",
"icms-19.5": "15546.05",
"icms-20.5": "15741.60",
"icms-22.5": "16147.84",
"icms-12-alc": "12697.42",
"icms-17-alc": "13462.31",
"icms-18-alc": "13626.49",
"icms-19-alc": "13794.71",
"icms-20-alc": "13967.15",
"icms-21-alc": "14143.95",
"icms-22-alc": "14325.28",
"icms-23-alc": "14511.32",
"withoutTaxes": "11173.72",
"icms-17.5-alc": "13543.91",
"icms-19.5-alc": "13880.40",
"icms-20.5-alc": "14054.99",
"icms-22.5-alc": "14417.70"
},
"pisCofinsList": "Negativa",
"substanceText": "ENZALUTAMIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "16787.85",
"icms-12": "19077.11",
"icms-17": "20226.32",
"icms-18": "20472.99",
"icms-19": "20725.75",
"icms-20": "20984.81",
"icms-21": "21250.45",
"icms-22": "21522.88",
"icms-23": "21802.39",
"icms-17.5": "20348.90",
"icms-19.5": "20854.47",
"icms-20.5": "21116.80",
"icms-22.5": "21661.75",
"icms-12-alc": "17553.44",
"icms-17-alc": "18610.85",
"icms-18-alc": "18837.82",
"icms-19-alc": "19070.38",
"icms-20-alc": "19308.77",
"icms-21-alc": "19553.18",
"icms-22-alc": "19803.86",
"icms-23-alc": "20061.05",
"withoutTaxes": "15447.01",
"icms-17.5-alc": "18723.66",
"icms-19.5-alc": "19188.84",
"icms-20.5-alc": "19430.20",
"icms-22.5-alc": "19931.62"
},
"invalidBarcodes": [],
"activeSubstances": [
"ENZALUTAMIDA"
],
"therapeuticClass": "L2B2 - HORMÔNIOS ANTIANDROGÊNICOS CITOSTÁTICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1771700060021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L2B2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:540315030002702"